ArticleApplied microbiology and biotechnology2026
Identification of fecal microbiome signatures associated with longevity through 16S rRNA sequencing in different age groups in China.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The gut microbiota plays a key role in aging and longevity. Therefore, identifying longevity-associated microbes in healthy and long-lived individuals and elucidating the molecular mechanisms through which they influence longevity are essential steps toward developing effective anti-aging interventions. In this study, we performed 16S rRNA sequencing on 301 fecal samples collected across three age groups. Long-lived individuals (≥ 90 years) had more diverse gut microbiota than typical older individuals (60-89 years), with diversity comparable to that of younger adults (45-59 years). Compared with typical older individuals, long-lived individuals exhibited a marked increase in the relative abundance of Bacteroidota and Akkermansia, accompanied by a decreased abundance of Prevotella_9 and Megamonas. Additionally, the microbiota from this age group showed significant enrichment in unsaturated fatty acid metabolism, ketone body synthesis and degradation, and tryptophan metabolism, suggesting that differences in microbiota composition and function may contribute to longevity. Finally, we developed a qPCR-based method to detect differentially abundant microbiota and established a classification model capable of distinguishing between age groups. In conclusion, the unique composition and function of the gut microbiota in long-lived individuals offer insights for identifying methods and targets for anti-aging interventions. KEY POINTS: • Long-lived individuals exhibited a marked increase in Bacteroidota and Akkermansia • Long-lived individuals exhibited enrichment in unsaturated fatty acid metabolism • We developed a qPCR-based method to detect differentially abundant microbiota.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.